JOHN JOHNSON - 01 Jun 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
John Johnson
Issuer symbol
AXGN
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Jun 2022, 16:14:05 UTC
Previous filing
20 Dec 2022
Next filing
09 Jun 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Employee Stock Option (right to purchase) Award $0 +11,811 $0.000000 11,811 01 Jun 2022 Common Stock 11,811 $9.29 Direct F1
transaction AXGN Restricted Stock Units Award $0 +6,459 $0.000000 6,459 01 Jun 2022 Common Stock 6,459 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.